Delivery Order SPE2DB22D2007-SPE2DB25FJ4XL
- Not listed
- The Defense Logistics Agency awarded a $1,178.86 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Fluorometholone 0.1% eye drops (5mL). This is a firm fixed price, competitively awarded contract with a completion date of August 8, 2025, and performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the company's capability to compete in open federal procurement processes. This...
- The Defense Logistics Agency awarded a delivery order valued at $8,091.98 to AmerisourceBergen Drug Corp for the supply of Fluorometholone 0.1% eye drops (10ml) with an ultimate completion date of September 10, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and is designated as a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed/delivered from AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Fluorometholone 0.1% eye drops (5mL) on August 28, 2025, with a contract ceiling value of $1,762.50. This is a firm fixed price delivery order with an ultimate completion date of August 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's established...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Fluorometholone 0.1% eye drops in 5ml units, with a contract ceiling value of $2,476.47. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 11,...
- The Defense Logistics Agency awarded a delivery order valued at $1,413.65 to AmerisourceBergen Drug Corp for Fluorometholone 0.1% eye drops (10mL) on August 21, 2025, with an ultimate completion date of August 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and specifies performance at the awardee's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $10,866.20 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Fluorometholone 0.1% eye drops in 10 milliliter quantities, with completion targeted for September 15, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Fluorometholone 0.1% eye drops in 10 mL quantities, with a ceiling value of $6,963.25. This is a firm fixed price delivery order with no set-aside designation, reflecting competitive procurement through open competition. The contract is set to be completed by July 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Fluorometholone 0.1% eye drops in a 10ml formulation. This competitively awarded, non-set-aside contract carries a ceiling value of $15,065.78 and represents a firm fixed price delivery order with an ultimate completion date of July 24, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency (DLA) awarded a $5,007.50 delivery order to AmerisourceBergen Drug Corp for Fluorometholone 0.1% Eye Drop 5ML, effective September 4, 2025, with completion anticipated by September 5, 2025. The contract employs firm fixed pricing with no small business set-aside and is classified as a child contract under a larger vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor supporting federal...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,254.26 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluorometholone 0.1% eye drops. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ4XLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,353.11 to AmerisourceBergen Drug Corp for the supply of Fluorometholone 0.1% eye drops in 5ml quantities. This competitively awarded, non-set-aside contract was issued on September 12, 2025, with an ultimate completion date of September 15, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract employs firm fixed pricing and represents a routine pharmaceutical procurement supporting federal medical supply needs. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen, as a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for the Defense Logistics Agency's Medical Supply Chain, providing a comprehensive portfolio of pharmaceutical products and medical supplies to support military healthcare operations globally. The parent contract encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains, enabling fulfillment of orders from the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/12/25 |